270 related articles for article (PubMed ID: 37521706)
1. The cellular mechanisms associated with the anesthetic and neuroprotective properties of xenon: a systematic review of the preclinical literature.
McGuigan S; Marie DJ; O'Bryan LJ; Flores FJ; Evered L; Silbert B; Scott DA
Front Neurosci; 2023; 17():1225191. PubMed ID: 37521706
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia.
Banks P; Franks NP; Dickinson R
Anesthesiology; 2010 Mar; 112(3):614-22. PubMed ID: 20124979
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Properties of Xenon.
Maze M; Laitio T
Mol Neurobiol; 2020 Jan; 57(1):118-124. PubMed ID: 31758401
[TBL] [Abstract][Full Text] [Related]
5. Preclinical neuroprotective actions of xenon and possible implications for human therapeutics: a narrative review.
Maze M
Can J Anaesth; 2016 Feb; 63(2):212-26. PubMed ID: 26507536
[TBL] [Abstract][Full Text] [Related]
6. Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol.
Yamakura T; Harris RA
Anesthesiology; 2000 Oct; 93(4):1095-101. PubMed ID: 11020766
[TBL] [Abstract][Full Text] [Related]
7. Methods for Defining the Neuroprotective Properties of Xenon.
Robel R; Caroccio P; Maze M
Methods Enzymol; 2018; 602():273-288. PubMed ID: 29588034
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective and neurotoxic properties of the 'inert' gas, xenon.
Ma D; Wilhelm S; Maze M; Franks NP
Br J Anaesth; 2002 Nov; 89(5):739-46. PubMed ID: 12393773
[TBL] [Abstract][Full Text] [Related]
9. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
10. XENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia.
Esencan E; Yuksel S; Tosun YB; Robinot A; Solaroglu I; Zhang JH
Med Gas Res; 2013 Feb; 3(1):4. PubMed ID: 23369273
[TBL] [Abstract][Full Text] [Related]
11. Effects of xenon on in vitro and in vivo models of neuronal injury.
Wilhelm S; Ma D; Maze M; Franks NP
Anesthesiology; 2002 Jun; 96(6):1485-91. PubMed ID: 12170064
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection by the noble gases argon and xenon as treatments for acquired brain injury: a preclinical systematic review and meta-analysis.
Liang M; Ahmad F; Dickinson R
Br J Anaesth; 2022 Aug; 129(2):200-218. PubMed ID: 35688658
[TBL] [Abstract][Full Text] [Related]
13. The neuroprotective effect and possible therapeutic application of xenon in neurological diseases.
Zhang M; Cui Y; Cheng Y; Wang Q; Sun H
J Neurosci Res; 2021 Dec; 99(12):3274-3283. PubMed ID: 34716615
[TBL] [Abstract][Full Text] [Related]
14. Digital Education for the Management of Chronic Wounds in Health Care Professionals: Protocol for a Systematic Review by the Digital Health Education Collaboration.
Martinengo L; Yeo NJY; Tang ZQ; Markandran KD; Kyaw BM; Tudor Car L
JMIR Res Protoc; 2019 Mar; 8(3):e12488. PubMed ID: 30907743
[TBL] [Abstract][Full Text] [Related]
15. Xenon-mediated neuroprotection in response to sustained, low-level excitotoxic stress.
Lavaur J; Lemaire M; Pype J; Le Nogue D; Hirsch EC; Michel PP
Cell Death Discov; 2016; 2():16018. PubMed ID: 27551511
[TBL] [Abstract][Full Text] [Related]
16. Identification of two mutations (F758W and F758Y) in the N-methyl-D-aspartate receptor glycine-binding site that selectively prevent competitive inhibition by xenon without affecting glycine binding.
Armstrong SP; Banks PJ; McKitrick TJ; Geldart CH; Edge CJ; Babla R; Simillis C; Franks NP; Dickinson R
Anesthesiology; 2012 Jul; 117(1):38-47. PubMed ID: 22634870
[TBL] [Abstract][Full Text] [Related]
17. The analgesic effect of xenon on the formalin test in rats: a comparison with nitrous oxide.
Fukuda T; Nishimoto C; Hisano S; Miyabe M; Toyooka H
Anesth Analg; 2002 Nov; 95(5):1300-4, table of contents. PubMed ID: 12401615
[TBL] [Abstract][Full Text] [Related]
18. Noble gas neuroprotection: xenon and argon protect against hypoxic-ischaemic injury in rat hippocampus in vitro via distinct mechanisms.
Koziakova M; Harris K; Edge CJ; Franks NP; White IL; Dickinson R
Br J Anaesth; 2019 Nov; 123(5):601-609. PubMed ID: 31470983
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the N-methyl-D-aspartate receptor glycine site.
Harris K; Armstrong SP; Campos-Pires R; Kiru L; Franks NP; Dickinson R
Anesthesiology; 2013 Nov; 119(5):1137-48. PubMed ID: 23867231
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic insights into xenon inhibition of NMDA receptors from MD simulations.
Liu LT; Xu Y; Tang P
J Phys Chem B; 2010 Jul; 114(27):9010-6. PubMed ID: 20560662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
